LANCET ONCOL 2021 10.1016/S1470-2045(21)00098-X

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

Friedlander¹, M; Moore, KN; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Lisyanskaya, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, WH; Liu, J; Mathews, C; Selle, F; Lortholary, A; Lowe, ES; Hettle, R; Flood, E; Parkhomenko, E; DiSilvestro, P

GYNECOL ONCOL 2021 10.1016/j.ygyno.2021.02.009

Metabolic syndrome and persistent cervical human papillomavirus infection

Lee¹, J; Kim, HS; Kim, K; Bae, DS; Kim, BG; Choi, CH

FRONT ONCOL 2021 10.3389/fonc.2021.670214

Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix

Jung¹, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY

J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e31

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

Lee¹, YJ; Lim, MC; Kim, BG; Ngoi, NY; Choi, CH; Park, SY; Tan, DSP; Go, YJ; Lee, JY

LANCET ONCOL 2020

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer interim results of a single-arm, phase 2 trial

Youn¹, JW; Hur, SY; Woo, JW; Kim, YM; Lim, MC; Park, SY; Seo, SS; No, JH; Kim, BG; Lee, JK; Shin, SJ; Kim, K; Chaney, MF; Choi, YJ; Suh, YS; Park, JS; Sung, YC

YONSEI MED J 2020 10.3349/ymj.2020.61.11.935

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

Shin¹, W; Noh, JJ; Seo, SS; Kang, S; Choi, CH; Park, SY; Kim, BG; Lim, MC

J CLIN MED 2020 10.3390/jcm9113471

Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type

Kang¹, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH

CANCERS 2020 10.3390/cancers12113188

Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041)

Choi¹, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY

CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557

Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer

Choi¹, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG

PHARMACEUTICS 2020 10.3390/pharmaceutics12100987

Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer

Noh¹, JJ; Kim, MS; Cho, YJ; Jeong, SY; Lee, YY; Ryu, JY; Choi, JJ; Bae, I; Wu, Z; Kim, BG; Hwang, JR; Lee, JW

J CLIN ONCOL 2020 10.1200/JCO.20.00799

Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation Subgroup Analysis Findings From the SOLO1 Trial

DiSilvestro¹, P; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, CA; Bradley, WH; Mathews, CA; Liu, J; Lowe, ES; Bloomfield, R; Moore, KN

BRIT J CANCER 2020 10.1038/s41416-020-01098-8

A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer

Kim¹, HS; Park, SY; Park, CY; Kim, YT; Kim, BJ; Song, YJ; Kim, BG; Kim, YB; Cho, CH; Kim, JH; Song, YS

FRONT ONCOL 2020 10.3389/fonc.2020.583515

Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor

Kang¹, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ

EUR J GYNAECOL ONCOL 2020 10.31083/j.ejgo.2020.04.5305

Malignant perivascular epithelioid cell tumor (PEComa) of uterus A case report with literature review

Noh¹, JJ; Hong, SY; Kim, BG

DIAGNOSTICS 2020 10.3390/diagnostics10080537

Ovarian Gynandroblastoma with a Juvenile Granulosa Cell Tumor Component in a Postmenopausal Woman

Hwang¹, S; Kim, BG; Song, SY; Kim, HS

GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.017

Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer

Choi¹, CH; Chung, JY; Kang, JH; Paik, ES; Lee, YY; Park, W; Byeon, SJ; Chung, EJ; Kim, BG; Hewitt, SM; Bae, DS

CANCER RES TREAT 2020 10.4143/crt.2019.328

Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status

Jeong¹, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

J CLIN MED 2020 10.3390/jcm9041137

Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis

Kim¹, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM

CURR PROB CANCER 2020 10.1016/j.currproblcancer.2019.100508

Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study

Choi¹, HJ; Lee, YY; Sohn, I; Kim, YM; Kim, JW; Kang, S; Kim, BG

Front Oncol 2020 10.3389/fonc.2020.00451

Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer

Paik¹, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ

OBSTET GYNECOL SURV 2020

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

Coleman¹, RL; Spirtos, NM; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, JW; Park, SY; Kim, BG; Nam, JH; Fujiwara, K; Walker, JL; Casey, AC; Secord, AA; Rubin, S; Chan, JK; DiSilvestro, P; Davidson, SA; Cohn, DE; Tewari, KS; Basen-Engquist, K; Huang, HQ; Brady, MF; Mannel, RS

J MINIM INVAS GYN 2020 10.1016/j.jmig.2019.04.005

In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model

Kim¹, J; Eom, HJ; Shin, H; Jeong, SY; Kim, MS; Yoon, HS; In, CH; Kim, BG; Bae, DS; Lee, JW

J CLIN MED 2020 10.3390/jcm9010147

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer

Choi¹, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG

GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004

CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer

Kim¹, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW

Asian Pac J Cancer Prev. 2019 Feb 26;20(2):425-435.

Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea

Hyunju Lee¹, Sooyoung Hur, Hyeongap Jang, I-Heng Lee, Woo-Yun Sohn, Georges Van Kriekinge, Byoung-Gie Kim

J OVARIAN RES 2019 10.1186/s13048-019-0602-5

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

Jeong¹, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY

NEW ENGL J MED 2019 10.1056/NEJMoa1902626

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

Coleman¹, RL; Spirtos, NM; Enserro, D; Herzog, TJ; Sabbatini, P; Armstrong, DK; Kim, JW; Park, SY; Kim, BG; Nam, JH; Fujiwara, K; Walker, JL; Casey, AC; Alvarez Secord, A; Rubin, S; Chan, JK; DiSilvestro, P; Davidson, SA; Cohn, DE; Tewari, KS; Basen-Engquist, K; Huang, HQ; Brady, MF; Mannel, RS

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Lee¹, JY; Kim, JW; Lim, MC; Kim, S; Kim, HS; Choi, CH; Yi, JY; Park, SY; Kim, BG; Nam, EJ; Kim, SW; Eoh, KJ; Lee, YJ; Roh, J; Kim, HM; Rae, DS; Lee, JW; Kim, TJ; Lee, YY; Choi, EH; Song, S; Kim, HS; Lee, M; Kim, SI; Lee, EJ; Kwon, SI; Shin, W; Seo, SS; Kang, S; Kim, MS; Kim, JS; Joung, J; Chung, J

J CLIN MED 2019 10.3390/jcm8111920

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study

Paik¹, ES; Lee, YJ; Lee, JY; Shin, W; Park, SY; Kim, SI; Kim, JW; Choi, CH; Kim, BG

SCI REP-UK 2019 10.1038/s41598-019-51959-3

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer

Lee¹, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW

PLOS MED 2019 10.1371/journal.pmed.1002893

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis

Yarmolinsky¹, J; Relton, CL; Lophatananon, A; Muir, K; Menon, U; Gentry-Maharaj, A; Walther, A; Zheng, J; Fasching, P; Zheng, W; Ling, WY; Park, SK; Kim, BG; Choi, JY; Park, B; Smith, GD; Martin, RM; Lewis, SJ

JPN J CLIN ONCOL 2019 10.1093/jjco/hyz085

An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION

Lee¹, JY; Yi, JY; Kim, HS; Lim, J; Kim, S; Nam, BH; Kim, HS; Kim, JW; Choi, CH; Kim, BG

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65

Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods

Paik¹, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW

GYNECOL ONCOL 2019 10.1016/j.ygyno.2019.02.023

Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women

Lawrenson¹, K; Song, FJ; Hazelett, DJ; Kar, SP; Tyrer, J; Phelan, CM; Corona, RI; Rodriguez-Malave, NI; Seo, JH; Adler, E; Coetzee, SG; Segato, F; Fonseca, MAS; Amos, CI; Carney, ME; Chenevix-Trench, G; Choi, J; Doherty, JA; Jia, WH; Jin, GJ; Kim, BG; Le, ND; Lee, J; Li, L; Lim, BK; Adenan, NA; Mizuno, M; Park, B; Pearce, CL; Shan, K; Shi, YY; Shu, XO; Sieh, W; Thompson, PJ; Wilkens, LR; Wei, QY; Woo, YL; Yan, L; Karlan, BY; Freedman, ML; Noushmehr, H; Goode, EL; Berchuck, A; Sellers, TA; Teo, SH; Zheng, W; Matsuo, K; Park, S; Chen, KX; Pharoah, PDP; Gayther, SA; Goodman, MT

J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?

Kim¹, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

Obstet Gynecol Sci. 2018 Jul;61(4):524-528. doi: 10.5468/ogs.2018.61.4.524. Epub 2018 Jul 5.

Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review

Myeong Seon Kim1¹, Chel-Hun Choi1, Tae-Joong Kim1, Jeong-Won Lee1, Jeeyun Lee2, Duk-Soo Bae1, Byoung-Gie Kim1

Obstet Gynecol Sci. 2018 May;61(3):319-327. doi: 10.5468/ogs.2018.61.3.319. Epub 2018 Apr 27.

Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea

Hye-joo Lee¹, Wonkyo Shin, Yun Jeong Jang, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim

Obstet Gynecol Sci. 2018 May;61(3):352-358. doi: 10.5468/ogs.2018.61.3.352. Epub 2018 May 9.

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer

Wonkyo Shin¹, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim

NEW ENGL J MED 2018 10.1056/NEJMoa1810858

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Moore¹, K; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; Lowe, ES; Bloomfield, R; DiSilvestro, P

Front Oncol 2018 10.3389/fonc.2018.00465

Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma

Kim¹, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM

EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034

The role of appendectomy in patients with mucinous borderline ovarian tumors

Song¹, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS

INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316

Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis

Choi¹, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG

BRIT J CANCER 2018 10.1038/s41416-018-0206-7

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

Aoki¹, Y; Ochiai, K; Lim, S; Aoki, D; Kamiura, S; Lin, H; Katsumata, N; Cha, SD; Kim, JH; Kim, BG; Hirashima, Y; Fujiwara, K; Kim, YT; Kim, SM; Chung, HH; Chang, TC; Kamura, T; Takizawa, K; Takeuchi, M; Kang, SB

J INFECT DIS 2018 10.1093/infdis/jiy133

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries

Garland¹, SM; Pitisuttithum, P; Ngan, HYS; Cho, CH; Lee, CY; Chen, CA; Yang, YC; Chu, TY; Twu, NF; Samakoses, R; Takeuchi, Y; Cheung, TH; Kim, SC; Huang, LM; Kim, BG; Kim, YT; Kim, KH; Song, YS; Lalwani, S; Kang, JH; Sakamoto, M; Ryu, HS; Bhatla, N; Yoshikawa, H; Ellison, MC; Han, SR; Moeller, E; Murata, S; Ritter, M; Sawata, M; Shields, C; Walia, A; Perez, G; Luxembourg, A

CANCER RES TREAT 2018 10.4143/crt.2017.104

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer

Paik¹, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis

Paik¹, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW

J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer

Paik¹, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

GYNECOL OBSTET INVES 2018 10.1159/000475817

Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis?

Song¹, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG

CANCER RES TREAT 2018 10.4143/crt.2016.376

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

Lee¹, SW; Kim, YM; Cho, CH; Kim, YT; Kim, SM; Hur, SY; Kim, JH; Kim, BG; Kim, SC; Ryu, HS; Kang, SB

INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000000602

Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study

Kim¹, JW; Mahner, S; Wu, LY; Shoji, T; Kim, BG; Zhu, JQ; Takano, T; Park, SY; Kong, BH; Wu, Q; Wang, KL; Ngan, HYS; Liu, JH; Wei, LH; Mitrica, I; Zhang, PK; Crescenzo, R; Wang, Q; Cox, CJ; Harter, P; du Bois, A

CANCER RES TREAT 2017 10.4143/crt.2016.322

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies

Heo¹, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW

EUR RADIOL 2017 10.1007/s00330-017-4765-4

Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids

Kim¹, YS; Kim, TJ; Lim, HK; Rhim, H; Jung, SH; Ahn, JH; Lee, JW; Kim, BG

J GYNECOL ONCOL 2017 10.3802/jgo.2017.28.e54

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference

Jang¹, JYA; Yanaihara, N; Pujade-Lauraine, E; Mikami, Y; Oda, K; Bookman, M; Ledermann, J; Shimada, M; Kiyokawa, T; Kim, BG; Matsumura, N; Kaku, T; Kuroda, T; Nagayoshi, Y; Kawabata, A; Iida, Y; Kim, JW; Quinn, M; Okamoto, A

CANCER RES TREAT 2017 10.4143/crt.2016.282

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer

Paik¹, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS

CANCER RES TREAT 2017 10.4143/crt.2016.034

Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer

Song¹, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW

SCI REP-UK 2017 10.1038/s41598-017-06510-7

The anti-cancer effects of itraconazole in epithelial ovarian cancer

Choi¹, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW

Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909.

Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients

Yang K1¹, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.

Mol Cancer Ther. 2016 Apr;15(4):618-27. doi: 10.1158/1535-7163.MCT-15-0733-T. Epub 2016 Feb 9.

Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma

Han HD1¹, Cho YJ2, Cho SK3, Byeon Y1, Jeon HN1, Kim HS4, Kim BG5, Bae DS5, Lopez-Berestein G6, Sood AK7, Shin BC8, Park YM9, Lee JW10.

Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:208-12. doi: 10.1016/j.ejogrb.2015.07.018. Epub 2015 Aug 20.

Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome

Song T1¹, Kim MK2, Lee YY3, Choi CH3, Kim TJ3, Lee JW3, Bae DS3, Kim BG4.

Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658.

Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer

Paik ES¹, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.

J Korean Med Sci. 2016 Dec;31(12):1969-1975. doi: 10.3346/jkms.2016.31.12.1969.

Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K)

Nam SH1¹, Choi HJ2, Kang WD3, Kim SM3, Lim MC4, Park SY4, Kim JS5, Kim BG2, Bae DS2, Lee JW2, Kim TJ2, Song T6.

Anticancer Res. 2016 Dec;36(12):6381-6388.

Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells

Lee YY1¹, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.

Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9.

Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery

Paik ES1¹, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.

Obstet Gynecol. 2016 Dec;128(6):1258-1264.

Regeneration Process After Cervical Conization for Cervical Intraepithelial Neoplasia

Song T1¹, Seong SJ, Kim BG.

Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502.

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

Kim HJ1¹, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.

J Gynecol Oncol. 2016 Nov;27(6):e64. doi: 10.3802/jgo.2016.27.e64.

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai

Chang HK1¹, Kim BG2, Shi TY3, Zang R4.

Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25.

Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis

Paik ES1¹, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9(10):19654-19663

Pulmonary benign metastasizing leiomyoma: clinical and therapeutic analyses of 11 patients treated at a single institution

Kim HS¹, Yoon G, Lee JS, Han J, Song SY, Kim BG, Bae DS, Lee JW

BMC Cancer. 2016 Jan 6;16:5. doi: 10.1186/s12885-015-2040-0.

Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea

Park B1¹,2, Park S3,4, Shin HR5, Shin A6,7, Yeo Y8, Choi JY9, Jung KW10, Kim BG11, Kim YM12, Noh DY13, Ahn SH14, Kim JW15, Kang S16, Kim JH17, Kim TJ18, Kang D19,20,21, Yoo KY22, Park SK23,24,25.

Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9.

Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum

Yoon G1¹, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.

Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762.

Long-term Outcomes of MRI Stage IIB Cervical Cancer

Yoon A1¹, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.

J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9.

Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer

Paik ES1¹, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.

J Clin Oncol. 2016 Aug 20;34(24):2881-7. doi: 10.1200/JCO.2016.66.9010. Epub 2016 Jul 11.

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Sugiyama T1¹, Okamoto A2, Enomoto T1, Hamano T1, Aotani E1, Terao Y1, Suzuki N1, Mikami M1, Yaegashi N1, Kato K1, Yoshikawa H1, Yokoyama Y1, Tanabe H1, Nishino K1, Nomura H1, Kim JW1, Kim BG1, Pignata S1, Alexandre J1, Green J1, Isonishi S1, Terauchi F1, Fujiwara K1, Aoki D1.

J Gynecol Oncol. 2016 Jul;27(4):e38. doi: 10.3802/jgo.2016.27.e38. Epub 2016 Apr 18.

Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer

Choi HJ1¹, Lee S2, Park BK3, Kim TJ1, Kim CK2, Park JJ2, Choi CH1, Lee YY1, Lee JW1, Bae DS1, Kim BG1.

Gynecol Oncol. 2016 Jun;141(3):440-446. doi: 10.1016/j.ygyno.2016.03.031. Epub 2016 Apr 8.

Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis

Kim TH1¹, Kim HS2, Kim TJ3, Chang SJ4, Kim DY5, Ryu SY1, Kim BG3, Kim YT6, Bae DS3, Ryu HS4, Nam JH6.

J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24.

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer

Paik ES1¹, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.

J Transl Med. 2016 May 6;14(1):124. doi: 10.1186/s12967-016-0874-0.

Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients

Choi CH1¹,2, Chung JY1, Kim JH3, Kim BG4, Hewitt SM5.

J Gynecol Oncol. 2016 May;27(3):e27. doi: 10.3802/jgo.2016.27.e27.

Time-lapse imaging of sentinel lymph node using indocyanine green with near-infrared fluorescence imaging in early endometrial cancer

Choi HJ1¹, Kim TJ2, Lee YY1, Lee JW1, Kim BG1, Bae DS1.

JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001

Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy

Kim TH1¹, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.

Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27.

Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation

Kim YS1¹, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.

J Gynecol Oncol. 2016 Mar;27(2):e20. doi: 10.3802/jgo.2016.27.e20.

Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer

Park JY1¹, Heo EJ1, Lee JW2, Lee YY1, Kim TJ1, Kim BG1, Bae DS1.

Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818.

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

Kim HS1¹, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.

J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222.

Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients

Kim TJ1¹, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.

Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283.

HER2 as a novel therapeutic target for cervical cancer

Oh DY1¹,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.

Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319.

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma

Lee YY1¹, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

J Gynecol Oncol. 2015 Oct;26(4):277-83. doi: 10.3802/jgo.2015.26.4.277. Epub 2015 Sep 23.

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group

Lee JY1¹, Kim K2, Lee TS3, Kang S4, Seong SJ5, Kim JW6, Kim BG7.

J Gynecol Oncol. 2015 Oct;26(4):270-6. doi: 10.3802/jgo.2015.26.4.270. Epub 2015 Jul 17.

Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors

Paik ES1¹, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Bae DS1, Kim BG2.

Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407.

Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches

Yoon A1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8.

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

Lee JW1¹, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.

Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1.

A prospective comparative study of cosmetic satisfaction for three different surgical approaches

Song T1¹, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.

Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16.

The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ

Song T1¹, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

Gynecol Oncol. 2015 Jun;137(3):412-7. doi: 10.1016/j.ygyno.2015.03.058. Epub 2015 Apr 11.

The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study

Suh DH1¹, Park JY2, Lee JY3, Kim BG4, Lim MC5, Kim JW3, Bae DS4, Park SY5, Nam JH2, Kim K1, No JH1, Kim YB6.

Hum Pathol. 2015 Jun;46(6):884-93. doi: 10.1016/j.humpath.2015.02.016. Epub 2015 Mar 11.

Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients

Choi CH1¹, Chung JY2, Park HS3, Jun M2, Lee YY4, Kim BG5, Hewitt SM6.

Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015.

Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis

Kim HS1¹, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.

Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404.

Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy

Yoon A1¹, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.

Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015.

Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands

Yoon G1¹, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.

Int J Clin Exp Pathol. 2015 May 1;8(5):5749-52. eCollection 2015.

Primary ovarian carcinoid tumor showing unusual histology and nuclear accumulation of beta-catenin

Kim HS1¹, Yoon G2, Jang HI3, Song SY4, Kim BG3.

Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005.

Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases

Kim TH1¹, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

PLoS One. 2015 Feb 6;10(2):e0116977. doi: 10.1371/journal.pone.0116977. eCollection 2015.

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma

Okamoto A1¹, Sehouli J2, Yanaihara N1, Hirata Y1, Braicu I2, Kim BG3, Takakura S1, Saito M1, Yanagida S1, Takenaka M1, Yamaguchi N1, Morikawa A1, Tanabe H1, Yamada K1, Yoshihara K4, Enomoto T4, Itamochi H5, Kigawa J5, Matsumura N6, Konishi I6, Aida S7, Aoki Y8, Ishii N8, Ochiai K1, Akiyama T7, Urashima M9.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14.

Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival

Song T1¹, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68.

Asian Society of Gynecologic Oncology International Workshop 2014

Park JY1¹, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.

J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62.

Single-site robotic surgery in gynecologic cancer: a pilot study

Yoo HN1¹, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):1025-30. eCollection 2015.

Decidualization of intranodal endometriosis in a postmenopausal woman

Kim HS1¹, Yoon G2, Kim BG2, Song SY1.

Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197.

Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix

Kim HJ1¹, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.

Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4.

Postoperative outcomes of MR-invisible stage IB1 cervical cancer

Park JY1¹, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.

J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31.

Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique

Choi CH1¹, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.

Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1.

Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation

Kim YS1¹, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.

J Clin Oncol. 2014 Oct 20;32(30):3374-82. doi: 10.1200/JCO.2014.55.7348. Epub 2014 Sep 15.

Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

du Bois A1¹, Floquet A1, Kim JW1, Rau J1, del Campo JM1, Friedlander M1, Pignata S1, Fujiwara K1, Vergote I1, Colombo N1, Mirza MR1, Monk BJ1, Kimmig R1, Ray-Coquard I1, Zang R1, Diaz-Padilla I1, Baumann KH1, Mouret-Reynier MA1, Kim JH1, Kurzeder C1, Lesoin A1, Vasey P1, Marth C1, Canzler U1, Scambia G1, Shimada M1, Calvert P1, Pujade-Lauraine E1, Kim BG1, Herzog TJ1, Mitrica I1, Schade-Brittinger C1, Wang Q1, Crescenzo R1, Harter P1.

Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232.

Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study

Kim TH1¹, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9.

Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma

Park YA1¹, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.

Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31.

Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases

Yoon A1¹, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.

Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041.

Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings

Kim HJ1¹, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):140-6. doi: 10.1016/j.ijrobp.2014.05.024. Epub 2014 Jul 8.

A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study

Cho H1¹, Nam BH2, Kim SM3, Cho CH4, Kim BG5, Ryu HS6, Kang SB7, Kim JH8.

Int J Gynecol Cancer. 2014 Sep;24(7):1206-14. doi: 10.1097/IGC.0000000000000216.

Risk Factors for Progression to Invasive Carcinoma in Patients With Borderline Ovarian Tumors

Song T1¹, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27.

Meta-analysis of the effects of beta blocker on survival time in cancer patients

Choi CH1¹, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.

Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12.

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

Choi CH1¹, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.

J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25.

Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy

Kim TJ1¹, Song T, Choi CH, Lee JW, Bae DS, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17.

Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma

Yoon A1¹, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.

PLoS One. 2014 Feb 11;9(2):e88587. doi: 10.1371/journal.pone.0088587. eCollection 2014.

Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines

Yoon H1¹, Choi YL2, Song JY1, Do I3, Kang SY4, Ko YH5, Song S4, Kim BG6.

Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6.

Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma

Park YA1¹, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.

Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015.

Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors

Yoon A1¹, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2013 Dec;131(3):650-4. doi: 10.1016/j.ygyno.2013.10.003. Epub 2013 Oct 18.

Genetic profiling to predict recurrence of early cervical cancer

Lee YY1¹, Kim TJ, Kim JY, Choi CH, Do IG, Song SY, Sohn I, Jung SH, Bae DS, Lee JW, Kim BG.

Gynecol Oncol. 2013 Nov;131(2):336-40. doi: 10.1016/j.ygyno.2013.07.110. Epub 2013 Aug 13.

Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: A Korean Gynecologic Oncology Group study (KGOG-3022)

Jung DC1¹, Kang S, Kim SC, Kim JW, Nam JH, Ryu SY, Seong SJ, Kim BG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):659-64. doi: 10.1016/j.ijrobp.2013.07.020.

Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03)

Lee HJ1¹, Han S, Kim YS, Nam JH, Kim HJ, Kim JW, Park W, Kim BG, Kim JH, Cha SD, Kim J, Lee KH, Yoon MS, Kim SM, Kim JY, Yoon WS, Lee NW, Choi JH, Park SY, Kim JY.

Gynecol Obstet Invest. 2013;76(4):241-7. doi: 10.1159/000356072. Epub 2013 Nov 1.

Endocervical-Like versus intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopatholigic Characteristics

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Sung CO, Song SY, Bae DS, Kim BG.

J Gynecol Oncol. 2013 Oct;24(4):291-2. doi: 10.3802/jgo.2013.24.4.291. Epub 2013 Oct 2.

Squamous cell carcinoma antigen in cervical cancer and beyond

¹,Kim BG1.

Int J Gynecol Cancer. 2013 Sep;23(7):1311-7. doi: 10.1097/IGC.0b013e31829da127.

Contributing Factors for Bone Metastasis in Uterine Cervical Cancer

Yoon A1¹, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2013 Jul;130(1):25-30. doi: 10.1016/j.ygyno.2013.04.011. Epub 2013 Apr 13.

A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma

Herzog TJ1¹, Scambia G, Kim BG, Lhomm? C, Markowska J, Ray-Coquard I, Sehouli J, Colombo N, Shan M, Petrenciuc O, Oza A.

Hum Pathol. 2013 Jun;44(6):1017-23. doi: 10.1016/j.humpath.2012.08.024. Epub 2013 Jan 3.

Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary

Choi CH1¹, Sung CO, Kim HJ, Lee YY, Song SY, Song T, Kim J, Kim TJ, Lee JW, Bae DS, Kim BG.

Cancer Genet. 2013 May;206(5):145-53. doi: 10.1016/j.cancergen.2013.04.002. Epub 2013 May 29.

Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma

Sung CO1¹, Choi CH, Ko YH, Ju H, Choi YL, Kim N, Kang SY, Ha SY, Choi K, Bae DS, Lee JW, Kim TJ, Song SY, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2013 Apr;167(2):215-8. doi: 10.1016/j.ejogrb.2012.11.027. Epub 2013 Jan 14.

Laparoendoscopic single site (LESS) surgery in benign gynecology: perioperative and late complications of 515 cases

¹,http://www.ncbi.nlm.nih.gov/pubmed/?term=Laparoendoscopic+single+site+(LESS)+surgery+in+benign+gynecology%3A+perioperative+and+late+complications+of+515+cases

J Gynecol Oncol. 2013 Apr;24(2):186-203. doi: 10.3802/jgo.2013.24.2.186. Epub 2013 Apr 5.

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition

Lee JK1¹, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH.

J Gynecol Oncol. 2013 Apr;24(2):120-7. doi: 10.3802/jgo.2013.24.2.120. Epub 2013 Apr 5.

A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system

Kim HJ1¹, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.

J Minim Invasive Gynecol. 2013 Mar-Apr;20(2):160-5. doi: 10.1016/j.jmig.2012.09.013. Epub 2013 Jan 11.

Laparoendoscopic Single-Site Surgery With Hysterectomy in Patients With Prior Cesarean Section: Comparison of Surgical Outcomes With Bladder Dissection Techniques

Jo EJ1¹, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.

J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8.

Histologic distribution of borderline ovarian tumors worldwide: a systematic review

Song T1¹, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Obstet Invest. 2012;74(4):313-9. doi: 10.1159/000338996. Epub 2012 Oct 11.

Uterine Endometrial Carcinoma: 10 Years' Experience with Long-Term Follow-Up at a Single Korean Institution

Lee EJ1¹, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Park HM, Kim BG.

Int J Clin Oncol. 2012 Dec;17(6):590-7. doi: 10.1007/s10147-011-0329-9. Epub 2011 Oct 13.

Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer

Song T1¹, Lee JW, Choi CH, Kim TJ, Bae DS, Sung CO, Song SY, Kim BG.

Gynecol Oncol. 2012 Oct;127(1):107-13. doi: 10.1016/j.ygyno.2012.05.039. Epub 2012 Jun 15.

Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer

Lee YY1¹, Choi CH, Sung CO, Do IG, Hub SJ, Kim HJ, Kim TJ, Lee JW, Bae DS, Kim BG.

J Gynecol Oncol. 2012 Oct;23(4):226-34. doi: 10.3802/jgo.2012.23.4.226. Epub 2012 Sep 19.

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer

Park JY1¹, Kim DY, Kim JH, Kim YM, Kim YT, Kim YS, Kim HJ, Lee JW, Kim BG, Bae DS, Huh SJ, Nam JH.

Aust N Z J Obstet Gynaecol. 2012 Oct;52(5):465-9. doi: 10.1111/j.1479-828X.2012.01466.x.

Cosmesis and body image after single-port access surgery for gynaecologic disease

Song T1¹, Kim TJ, Cho J, Kim IR, Kang PN, Lee JW, Bae DS, Kim BG.

Asian Pac J Cancer Prev. 2012;13(8):3731-40.

Korean Epithelial Ovarian Cancer Study (Ko-EVE): Protocols and Interim Report

Ma SH1¹, Kim BG, Choi JY, Kim TJ, Kim YM, Kim JW, Kang S, Kang D, Yoo KY, Park SK.

Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005. Epub 2012 Mar 2.

High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

Kim HJ1¹, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.

Cancer Res Treat. 2012 Jun;44(2):142-5. doi: 10.4143/crt.2012.44.2.142. Epub 2012 Jun 30.

Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review

Kim MK1¹, Kim SH, Lee YY, Choi CH, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

Br J Cancer. 2012 Jun 26;107(1):91-9. doi: 10.1038/bjc.2012.217. Epub 2012 May 29.

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival

Choi CH1¹, Choi JJ, Park YA, Lee YY, Song SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, Kim HJ, Bae DS, Kim BG.

Ann Surg Oncol. 2012 Jun;19(6):1973-9. doi: 10.1245/s10434-011-2148-7. Epub 2011 Dec 20.

Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study

Kim HS1¹, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW.

PLoS One. 2012;7(5):e35399. doi: 10.1371/journal.pone.0035399. Epub 2012 May 18.

Thymosin beta(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production

Kim YC1¹, Kim BG, Lee JH.

Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28.

Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer

Song T1¹, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.

Int J Gynecol Cancer. 2012 May;22(4):611-6. doi: 10.1097/IGC.0b013e318249472d.

Patterns of Recurrence in Endometrial Cancer Patients at Risk of Lymph Node Metastasis or Recurrence According to Extent of Lymphadenectomy

Kim HJ1¹, Kim TJ, Song T, Kim MK, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.

Anticancer Res. 2012 Apr;32(4):1555-61.

Pretreatment Neutrophil:Lymphocyte Ratio as a Prognostic Factor in Cervical Carcinoma

Lee YY1¹, Choi CH, Kim HJ, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

J Gynecol Oncol. 2012 Jan;23(1):72-3. doi: 10.3802/jgo.2012.23.1.72. Epub 2012 Jan 9.

Hereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium In reply

Yoo HJ1¹, Park SY, Lim MC.

J Gynecol Oncol. 2011 Dec;22(4):233-8. doi: 10.3802/jgo.2011.22.4.233. Epub 2011 Dec 5.

Synchronous gynecologic malignancy and preliminary results of Lynch syndrome

Kim MK1¹, Song SY, Do IG, Kim SH, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1252-7. doi: 10.1016/j.ijrobp.2010.07.2006. Epub 2010 Nov 13.

A MATCHED-CASE COMPARISON TO EXPLORE THE ROLE OF CONSOLIDATION CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION IN CERVICAL CANCER

Choi CH1¹, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, Huh SJ, Lee JH, Bae DS, Kim BG.

Taiwan J Obstet Gynecol. 2011 Dec;50(4):436-40. doi: 10.1016/j.tjog.2011.10.007.

Single-port access laparoscopic surgery using a novel laparoscopic port (Octo-Port)

Song T1¹, Kim TJ, Kang HJ, Choi CH, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Sep;122(3):541-7. doi: 10.1016/j.ygyno.2011.05.009. Epub 2011 Jun 2.

Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis

Lee YY1¹, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Aug;122(2):361-5. doi: 10.1016/j.ygyno.2011.04.025. Epub 2011 May 13.

Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy

Lee YY1¹, Choi CH, Do IG, Song SY, Lee W, Park HS, Song TJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.

Hum Reprod. 2011 Aug;26(8):2008-14. doi: 10.1093/humrep/der119. Epub 2011 Apr 21.

Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours

Song T1¹, Hun Choi C, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Jul;122(1):127-31. doi: 10.1016/j.ygyno.2011.03.021. Epub 2011 Apr 13.

Accuracy of frozen section diagnosis of borderline ovarian tumors

Song T1¹, Choi CH, Kim HJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2011 Jul;122(1):79-82. doi: 10.1016/j.ygyno.2011.03.017. Epub 2011 Apr 13.

Prognostic significance of DNA ploidy in stage I endometrial cancer

Song T1¹, Lee JW, Kim HJ, Kim MK, Choi CH, Kim TJ, Bae DS, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):204-8. doi: 10.1016/j.ejogrb.2011.01.009. Epub 2011 Feb 8.

Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors

Song T1¹, Choi CH, Kim HJ, Lee W, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Cancer Res Treat. 2011 Jun;43(2):131-3. doi: 10.4143/crt.2011.43.2.131. Epub 2011 Jun 30.

Benign Metastasizing Leiomyoma with Multiple Lymph Node Metastasis: A Case Report

Yoon G1¹, Kim TJ, Sung CO, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.

Cancer. 2011 May 15;117(10):2104-11. doi: 10.1002/cncr.25710. Epub 2010 Nov 29.

Phase II Study of Belotecan, a Camptothecin Analogue, in Combination With Carboplatin for the Treatment of Recurrent Ovarian Cancer

Choi CH1¹, Lee YY, Song TJ, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

Int J Gynecol Cancer. 2011 May;21(4):640-6. doi: 10.1097/IGC.0b013e3182129842.

Fertility-Sparing Surgery for Borderline Ovarian Tumors Oncologic Safety and Reproductive Outcomes

Song T1¹, Choi CH, Park HS, Kim MK, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Eur J Cancer. 2011 Apr;47(6):918-25. doi: 10.1016/j.ejca.2010.11.007. Epub 2010 Dec 4.

High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma

Kim CJ1¹, Lee JW, Choi JJ, Choi HY, Park YA, Jeon HK, Sung CO, Song SY, Lee YY, Choi CH, Kim TJ, Lee JH, Kim BG, Bae DS.

J Gynecol Oncol. 2011 Mar 31;22(1):44-8. doi: 10.3802/jgo.2011.22.1.44.

Clinical significance of HIF-2 alpha immunostaining area in radioresistant cervical cancer

Kim MK1¹, Kim TJ, Sung CO, Choi CH, Lee JW, Bae DS, Kim BG.

Exp Mol Med. 2011 Feb 28;43(2):91-100.

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration

Park K1¹, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH.

Gynecol Oncol. 2011 Jan;120(1):18-22. doi: 10.1016/j.ygyno.2010.09.024. Epub 2010 Oct 28.

Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Kang S1¹, Kim TJ, Seo SS, Kim BG, Bae DS, Park SY.

Gynecol Oncol. 2011 Jan;120(1):56-62. doi: 10.1016/j.ygyno.2010.09.022. Epub 2010 Oct 28.

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

Lee JW1¹, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.

J Gynecol Oncol. 2010 Dec 30;21(4):241-7. doi: 10.3802/jgo.2010.21.4.241. Epub 2010 Dec 31.

Epidemiological characteristics of ovarian cancer in Korea

Park B1¹, Park S, Kim TJ, Ma SH, Kim BG, Kim YM, Kim JW, Kang S, Kim J, Kim TJ, Yoo KY, Park SK.

J Pediatr Surg. 2010 Oct;45(10):1955-60. doi: 10.1016/j.jpedsurg.2010.06.012.

Pediatric borderline ovarian tumors: a retrospective analysis

Song T1¹, Choi CH, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.

Gynecol Oncol. 2010 Oct;119(1):87-91. doi: 10.1016/j.ygyno.2010.05.030. Epub 2010 Jun 26.

Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer

Lee YY1¹, Lee JW, Park HS, Song TJ, Kim MK, Choi CH, Kim TJ, Lee JH, Bae DS, Kim BG.

Surg Endosc. 2010 Sep;24(9):2248-52. doi: 10.1007/s00464-010-0944-y. Epub 2010 Feb 23.

Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes

Kim TJ1¹, Lee YY, Cha HH, Kim CJ, Choi CH, Lee JW, Bae DS, Lee JH, Kim BG.

Int J Gynecol Cancer. 2010 Aug;20(6):1017-24. doi: 10.1111/IGC.0b013e3181e4a704.

Prevalence and Predictors of Anxiety and Depression Among Cervical Cancer Survivors in Korea

Kim SH1¹, Kang S, Kim YM, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH.

Eur J Obstet Gynecol Reprod Biol. 2010 Aug;151(2):181-4. doi: 10.1016/j.ejogrb.2010.03.010. Epub 2010 Apr 13.

Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of pen-operative outcomes

Lee YY1¹, Kim TJ, Kim CJ, Park HS, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.

Int J Gynecol Cancer. 2010 Jul;20(5):798-803.

Peritoneal Tuberculosis A Retrospective Review of 20 Cases and Comparison With Primary Peritoneal Carcinoma

Choi CH1¹, Kim CJ, Lee YY, Kim JS, Song T, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

FEBS Lett. 2010 Apr 16;584(8):1469-75. doi: 10.1016/j.febslet.2010.02.072. Epub 2010 Mar 6.

Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells

Yeom SY1¹, Jang HL, Lee SJ, Kim E, Son HJ, Kim BG, Park C.

J Korean Med Sci. 2010 Apr;25(4):552-6. doi: 10.3346/jkms.2010.25.4.552. Epub 2010 Mar 19.

Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion

Lee TS1¹, Kim JW, Kim DY, Kim YT, Lee KH, Kim BG, McMeekin DS.

Gynecol Oncol. 2010 Mar;116(3):533-8. doi: 10.1016/j.ygyno.2009.11.018. Epub 2009 Dec 14.

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: A clinicopathologic study of 131 cases and literature review

Lee EJ1¹, Kim TJ, Kim DS, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):97-101. doi: 10.1016/j.ejogrb.2009.11.011. Epub 2009 Dec 16.

The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries

Kim WY1¹, Kim TJ, Kim SE, Lee JW, Lee JH, Kim BG, Bae DS.

J Surg Oncol. 2010 Jan 1;101(1):13-7. doi: 10.1002/jso.21398.

Preoperative Serum CA-125 Levels and Risk of Suboptimal Cytoreduction in Ovarian Cancer: A Meta-Analysis

Kang S1¹, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, Park SY.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1513-20. doi: 10.1007/s00432-009-0598-0. Epub 2009 May 16.

In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study

Kim HS1¹, Kim TJ, Chung HH, Kim JW, Kim BG, Park NH, Song YS, Bae DS, Kang SB.

Gynecol Oncol. 2009 Oct;115(1):65-8. doi: 10.1016/j.ygyno.2009.06.022. Epub 2009 Jul 15.

The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results

Lee YY1¹, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.

J Korean Med Sci. 2009 Oct;24(5):945-50. doi: 10.3346/jkms.2009.24.5.945. Epub 2009 Sep 24.

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer

Kang H1¹, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.

Gynecol Oncol. 2009 Aug;114(2):210-4. doi: 10.1016/j.ygyno.2009.04.016. Epub 2009 May 14.

Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study

Kang H1¹, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG.

Ann Oncol. 2009 Jun;20(6):1032-6. doi: 10.1093/annonc/mdn764. Epub 2009 Feb 4.

Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective study of Korean Gynecologic Oncology Group

Ryu SY1¹, Park SI, Nam BH, Kim I, Yoo CW, Nam JH, Lee KH, Cho CH, Kim JH, Park SY, Kim BG, Kang SB.

Conization Using Electrosurgical Conization and Cold Coagulation for International Federation of Gynecology and Obstetrics Stage IA(1) Squamous Cell Carcinomas of the Uterine Cervix

Int J Gynecol Cancer. 2009 Jan;19(1):84-7. doi: 10.1111/IGC.0b013e31819914c5.

Clinicopathologic Characteristics of Malignant Germ Cell Tumors in the Ovaries of Korean Women A Korean Gynecologic Oncology Group Study

Lee KH1¹, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB, Ryu SY, Cho CH, Choi HS, Kim KT; Korean Gynecologic Oncology Group.

Oncology. 2009;76(3):190-8. doi: 10.1159/000201571. Epub 2009 Feb 11.

Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module

Shin DW1¹, Ahn E, Kim YM, Kang S, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):916-20. doi: 10.1111/j.1525-1438.2007.01146.x. Epub 2008 Jan 31.

Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005)

Lee JK1¹, Song SH, Kim I, Lee KH, Kim BG, Kim JW, Kim YT, Park SY, Cha MS, Kang SB.

Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231.

Altered MicroRNA expression in cervical carcinomas

Lee JW1¹, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199-204. Epub 2007 Nov 26.

Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation

Choi CH1¹, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS.

Oncol Rep. 2008 Apr;19(4):859-63.

Increased expression of calpain 6 during the progression of uterine cervical neoplasia: Immunohistochemical analysis

Lee SJ1¹, Kim BG, Choi YL, Lee JW.

Cancer Sci. 2008 Jan;99(1):31-8. Epub 2007 Nov 6.

Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer

Kim TJ1¹, Choi JJ, Kim WY, Choi CH, Lee JW, Bae DS, Son DS, Kim J, Park BK, Ahn G, Cho EY, Kim BG.

Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1252-7. Epub 2007 Apr 18.

Prognostic factors associated with brain metastases from epithelial ovarian carcinoma

Kim TJ1¹, Song S, Kim CK, Kim WY, Choi CH, Lee JH, Lee JW, Bae DS, Kim BG.

Cancer Lett. 2007 Sep 18;255(1):26-33. Epub 2007 Apr 30.

Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer

Choi CH1¹, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26.

Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results

Choi CH1¹, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.

Gynecol Oncol. 2007 Jun;105(3):762-8. Epub 2007 Mar 26.

Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma

Choi CH1¹, Kim TJ, Kim WY, Ahn GH, Lee JW, Kim BG, Lee JH, Bae DS.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53.

Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis

Lee SJ1¹, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH.

Gynecol Oncol. 2007 Jan;104(1):64-9. Epub 2006 Aug 10.

Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma

Choi CH1¹, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.

Gynecol Oncol. 2006 Oct;103(1):363-7. Epub 2006 Jun 30.

Squamous cell carcinoma with sarcomatoid features of the vulva: A case report and review of literature

Choi DS1¹, Lee JW, Lee SJ, Choi CH, Kim TJ, Lee JH, Bae DS, Ahn G, Kim BG.

Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):243-7. Epub 2006 Feb 28.

Expression of CD44 adhesion molecules on human placentae

Choi CH1¹, Roh CR, Kim TJ, Choi YL, Lee JW, Kim BG, Lee JH, Bae DS.

Hum Pathol. 2006 Jul;37(7):906-13. Epub 2006 May 26.

High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis

Kim TJ1¹, Rho SB, Choi YL, Choi CH, Lee JW, Bae DS, Ahn G, Lee JH, Kim BG.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1157-64.

Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix

Choi CH1¹, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):664-9.

Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management

Lee SJ1¹, Jung KL, Lee JW, Song SY, Kim BG, Lee JH, Park CS, Bae DS.

Oncol Rep. 2006 Mar;15(3):565-9.

Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families

Kim TJ1¹, Lee KM, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG.

J Obstet Gynaecol Res. 2006 Feb;32(1):99-106.

Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery

Lee SJ1¹, Kim BG, Lee JW, Park CS, Lee JH, Bae DS.

Gynecol Oncol. 2006 Feb;100(2):422-5. Epub 2005 Sep 27.

Adenoid cystic carcinoma of the Bartholin's gland: Report of two cases and review of the literature

Yang SY1¹, Lee JW, Kim WS, Jung KL, Lee SJ, Lee JH, Bae DS, Kim BG.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):95-100.

A pilot study of three-cycle consolidation chemotherapy with paclitaxel and platinum in epithelial ovarian cancer patients with clinical complete response after paclitaxel and platinum chemotherapy

Lee SJ1¹, Lee JW, Min JA, Park CS, Kim BG, Lee JH, Bae DS.

Int J Cancer. 2005 Nov 1;117(2):194-201.

Increased, expression of ICAM-3 is associated with radiation resistance in cervical cancer

Chung YM1¹, Kim BG, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS.

Gynecol Oncol. 2005 Apr;97(1):53-9.

Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia

Lee JW1¹, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS.

Int J Gynecol Cancer. 2005 Jan-Feb;15(1):146-54.

Profiling of differentially expressed genes in human uterine leiomyomas

Lee EJ1¹, Kong G, Lee SH, Rho SB, Park CS, Kim BG, Bae DS, Kavanagh JJ, Lee JH.